These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 37167084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. OCT2 expression in histiocytoses.
    Ungureanu IA, Cohen-Aubart F, Héritier S, Fraitag S, Charlotte F, Lequain H, Hélias-Rodzewicz Z, Haroche J, Donadieu J, Emile JF.
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [Abstract] [Full Text] [Related]

  • 5. Challenges in the Histopathologic Diagnosis of Histiocytic Neoplasms.
    Rech KL, He R.
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1305-1311. PubMed ID: 34781270
    [Abstract] [Full Text] [Related]

  • 6. [Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].
    Chen YP, Jiang XN, Lu JP, Zhang H, Li XQ, Chen G.
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug 08; 45(8):556-60. PubMed ID: 27510782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strong Coexpression of Transcription Factors PU.1 and Oct-2 in Rosai-Dorfman Disease.
    Kiruthiga KG, Younes S, Natkunam Y.
    Am J Clin Pathol; 2022 Dec 01; 158(6):672-677. PubMed ID: 36239684
    [Abstract] [Full Text] [Related]

  • 10. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
    Bösmüller H, Nann D, Horger M, Fend F.
    Pathologe; 2015 Sep 01; 36(5):458-66. PubMed ID: 26305142
    [Abstract] [Full Text] [Related]

  • 11. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J, Abla O.
    Hematology Am Soc Hematol Educ Program; 2015 Sep 01; 2015():571-8. PubMed ID: 26637774
    [Abstract] [Full Text] [Related]

  • 12. BRAF mutation leading to central nervous system rosai-dorfman disease.
    Richardson TE, Wachsmann M, Oliver D, Abedin Z, Ye D, Burns DK, Raisanen JM, Greenberg BM, Hatanpaa KJ.
    Ann Neurol; 2018 Jul 01; 84(1):147-152. PubMed ID: 30014527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases].
    Dong RF, Gong LH, Zhang W, Li L, Sun XQ, Zhang M, Ding Y.
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep 08; 49(9):904-909. PubMed ID: 32892555
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary Rosai-Dorfman disease of the central nervous system: A clinical, histological, and molecular appraisal.
    Parkhi M, Chatterjee D, Kashyap D, Aggarwal A, Radotra B.
    Neuropathology; 2024 Oct 08; 44(5):366-375. PubMed ID: 38548480
    [Abstract] [Full Text] [Related]

  • 18. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
    Friedman JS, Durham BH, Reiner AS, Yabe M, Petrova-Drus K, Dogan A, Pulitzer M, Busam KJ, Francis JH, Rampal RK, Ulaner GA, Reddy R, Yeh R, Hatzoglou V, Lacouture ME, Rotemberg V, Mazor RD, Hershkovitz-Rokah O, Shpilberg O, Goyal G, Go RS, Abeykoon JP, Rech K, Morlote D, Fidai S, Gannamani V, Zia M, Abdel-Wahab O, Panageas KS, Rosenblum MK, Diamond EL.
    Br J Haematol; 2024 Jul 08; 205(1):127-137. PubMed ID: 38613141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.